LPA and metabolic syndrome: Additionally, alterations in the ATX-LPA pathway have been implicated in metabolic and inflammatory disorders, such as obesity, insulin resistance, metabolic syndrome, cardiovascular disease, neurogenesis, and cancer [28, 29].